henry labs semaglutide – Confused about new dose/formula :
Description
6.1% on compounded semaglutide
We don't know if it's functionally the same as original cartilage
Similarly, in the STEP-HFpEF DM trial, which included 616 obese HFpEF patients with comorbid T2DM, once-weekly semaglutide 2.4 mg improved the KCCQ-CSS by 13.7 points versus 6.4 points with placebo at 52 weeks [103]
Body weight and atherosclerosis Obesity is a significant risk factor for T2DM and an independent risk factor for ASCVD [45]
